ASP Isotopes Inc. (NASDAQ:ASPI) Shares Acquired by Jane Street Group LLC

Jane Street Group LLC boosted its stake in ASP Isotopes Inc. (NASDAQ:ASPIFree Report) by 31.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 145,969 shares of the company’s stock after purchasing an additional 35,166 shares during the period. Jane Street Group LLC’s holdings in ASP Isotopes were worth $406,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp purchased a new stake in shares of ASP Isotopes in the second quarter worth about $381,000. Rhumbline Advisers acquired a new position in shares of ASP Isotopes in the second quarter worth about $116,000. Rathbones Group PLC boosted its holdings in ASP Isotopes by 27.5% in the second quarter. Rathbones Group PLC now owns 195,915 shares of the company’s stock valued at $600,000 after purchasing an additional 42,243 shares during the last quarter. Renaissance Technologies LLC grew its stake in ASP Isotopes by 5.7% during the 2nd quarter. Renaissance Technologies LLC now owns 171,800 shares of the company’s stock valued at $526,000 after purchasing an additional 9,200 shares in the last quarter. Finally, Marshall Wace LLP grew its position in shares of ASP Isotopes by 389.6% during the second quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock worth $1,668,000 after buying an additional 433,734 shares in the last quarter. 16.80% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Canaccord Genuity Group started coverage on ASP Isotopes in a research note on Friday, October 4th. They set a “buy” rating and a $4.50 price objective on the stock. Canaccord Genuity Group reiterated a “buy” rating and set a $4.50 price target on shares of ASP Isotopes in a research report on Friday, October 18th.

Check Out Our Latest Stock Report on ASPI

ASP Isotopes Stock Down 6.2 %

ASP Isotopes stock opened at $4.72 on Wednesday. ASP Isotopes Inc. has a one year low of $1.72 and a one year high of $9.33. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55. The firm has a market capitalization of $336.96 million, a P/E ratio of -7.74 and a beta of 3.48. The company has a 50-day simple moving average of $5.91 and a 200-day simple moving average of $3.99.

About ASP Isotopes

(Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Featured Stories

Want to see what other hedge funds are holding ASPI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ASP Isotopes Inc. (NASDAQ:ASPIFree Report).

Institutional Ownership by Quarter for ASP Isotopes (NASDAQ:ASPI)

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.